#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Plasma cell myeloma refractory Cutaneous T-cell lymphoma recurrent Hypereosinophilic syndrome Fusarium infection Burkitt's lymphoma Metastatic gastric cancer Ewing's sarcoma recurrent Myelodysplastic syndrome with excess blasts Juvenile idiopathic arthritis Retinal dystrophy Peritoneal mesothelioma malignant Autoimmune disorder Warm autoimmune haemolytic anaemia Gastroenteropancreatic neuroendocrine tumour disease Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome – Basic Information Encephalitis autoimmune – Trials in Disease Usher’s syndrome – Diagnostics MELAS syndrome – Diagnostics Hereditary ataxia – Basic Information Pelizaeus-Merzbacher disease – Treatment Pelizaeus-Merzbacher disease – Life with Disease Mitochondrial myopathy – Treatment Alveolar rhabdomyosarcoma – Diagnostics Fabry’s disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tecovirimat Levonorgestrel Quemliclustat Epacadostat Tetracycline Hydrochloride Simeticone Opevesostat Tosilate Alpha-Tocopherol Quercus Ilex Allergen Extract Bepranemab Amiloride Hydrochloride Simoctocog Alfa Imetelstat Sodium Hepatitis B Surface Antigen Sulfasalazine Ammonium Chloride Follitropin Alfa Mva-209-Fsp-B3 Ptc518 Baxdrostat More therapies…

    Learn about Your Condition

    Generalised anxiety disorder Hodgkin's disease recurrent Hypotonia Reperfusion injury Frontotemporal dementia Oesophageal cancer metastatic Seizure Anaemia of pregnancy Antithrombin III deficiency Vulvar dysplasia Prinzmetal angina Overweight Brain cancer metastatic Raynaud's phenomenon Foot deformity More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Fluoxetine and E-therapy for Men Seeking Help with Pedophilic Disorder

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Paedophilia
    Investigated Drugs:
    • Fluoxetine
    Sweden

  • Study on Short-term Interruption vs. Continuous Anticoagulation with Apixaban in Patients Undergoing Colorectal Polypectomy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acenocoumarol
    • Lactose Monohydrate
    • Warfarin Sodium
    Spain

  • Study on Adding Zoledronic Acid or Denosumab to Radiotherapy for Adults with Inoperable Vertebral Bone Metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cancer pain
    • Metastatic neoplasm
    Investigated Drugs:
    • Denosumab
    • Zoledronic Acid Monohydrate
    France

  • Study on Preventing Peritoneal Metastases in High-Risk Colorectal Cancer Patients Using Fluorouracil, Oxaliplatin, and Levoleucovorin After Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Levoleucovorin
    • Fluorouracil
    • Oxaliplatin
    Italy

  • Study Comparing Mezigdomide, Bortezomib, and Dexamethasone with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Mezigdomide
    • Bortezomib
    • Pomalidomide
    Austria Belgium Czechia Finland France Germany +7

  • Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Balcinrenone
    • Dapagliflozin
    Austria Bulgaria Czechia Finland France Germany +9
Previous Page
1 … 505 506 507 508 509 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!